---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-26-007951"
form_type: "8-K"
ticker: "ADIA"
cik: "0001160420"
company_name: "Adia Nutrition, Inc."
filed_at: "2026-10-19T15:22:28+00:00"
generated_at: "2026-10-19T15:23:06.731031+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Adia Med sells 7% of Adia Labs LLC to CEO Larry Powalisz for $350,000 cash in related-party deal

## Summary
- Adia Med sold 7 of 100 units in subsidiary Adia Labs LLC to CEO Larry Powalisz for $350,000 cash, or $50,000 per unit, per the Oct 13, 2026 agreement.
- The units carry a 7% membership interest and 7% of total voting power (one vote per unit of 100); operating agreement to be amended at closing.
- Related-party terms: Powalisz buys as an individual; independent directors Monica Sher, M.D. and Richard Edwards, D.O. signed for Adia Med and must jointly approve in writing any use of the proceeds.
- Powalisz has no unilateral authority to direct spending of the purchase price or to approve/execute amendments on the seller's behalf.
- Closing needs full wire payment plus buyer joinder and updated cap table; deal terminates if not closed within 10 days of effectiveness. Live Oak Health (QCM Biologics) consented.

## SEC filing metadata
- accession: 0001683168-26-007951
- form_type: 8-K
- ticker: ADIA
- cik: 0001160420
- company_name: Adia Nutrition, Inc.
- filed_at: 2026-10-19T15:22:28+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1160420/000168316826007951/0001683168-26-007951-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1160420/000168316826007951/adia_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-26-007951
- JSON: https://secwatch.observer/filing/0001683168-26-007951.json
- Plain text: https://secwatch.observer/filing/0001683168-26-007951.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.